Curia Expands Glasgow Manufacturing Capacity and Enhances Cell Line Development Platform

ALBANY, N.Y., March 24 (Bernama-GLOBE NEWSWIRE) — Curia, a leading contract research, development and manufacturing organization (CDMO), today announced progress on the expansion at its Glasgow, UK sterile drug product facility as well as enhancements to its proprietary platform for cell line development.

The Glasgow, UK, site is well known throughout the industry for its more than 25 years of experience with formulation, lyophilization development and sterile fill-finish capabilities, including ADCs and other highly potent products. The current expansion is expected to be completed by early 2027. The investment will add an Annex 1 compliant isolator-based vial filling line and lyophilizer. Once complete, Glasgow will be able to fill batches up to 20,000 vials and will be well‑positioned to support future small‑scale commercial fills.

“This expansion in Glasgow comes as Curia is nearing completion of our significant expansion in our commercial drug product facility in Albuquerque, NM,” said Ron Aungst, VP, Drug Product Business Unit Operations. “Curia has already secured crucial equipment with long lead times to help the Glasgow expansion project stay on track, and we do not anticipate any disruption to current operations during the expansion.”

Curia’s clinical drug substance development capabilities have also been enhanced with improvements to the company’s cell line development (CLD) platform. The CLD offering at Curia’s Hopkinton, MA facility has been enhanced to incorporate IP-free semi-targeted integration technology that results in 6-fold higher titers compared to random integration technology. Curia’s stable platform, CHO-GSN®, was derived from the same parental cell line as its transient platform, TunaCHO®, allowing partners to efficiently scale-up from discovery to GMP.

“Our biologics division has always had end-to-end capabilities, and we are excited to offer a cell line that makes it more cost-efficient and faster to advance partners through early-stage clinical manufacturing,” said Jamie Grabowski, President, Research & Development. “With biotech-friendly licensing terms, reengineered cell line will be a critical component of successfully guiding partners on their path to commercialization.”

About Curia
Curia is a contract research, development and manufacturing organization (CDMO) with over 30 years of experience, an integrated network of 20+ global sites and 3,100 employees partnering with biopharmaceutical customers to bring life-changing therapies to market. Our offerings in small molecule, generic APIs and biologics span discovery through commercialization, with integrated regulatory, analytical and sterile fill-finish capabilities. Our scientific and process experts, along with our regulatory compliant facilities, provide a best-in-class experience across drug substance and drug product manufacturing. From curiosity to cure, we deliver every step to accelerate your research and improve patients’ lives. Visit us at curiaglobal.com.

Corporate Contact:
Viana Bhagan
Curia
+1 518 512 2111
corporatecommunications@CuriaGlobal.com

SOURCE: Curia Global, Inc.

EarthDaily Achieves CEOS Analysis Ready Data (CEOS-ARD) Compliance

Validation Confirms Science-Grade Integrity of the EarthDaily Constellation 

VANCOUVER, British Columbia and NEW YORK, March 13 (Bernama-GLOBE NEWSWIRE) — EarthDaily today announced that its data products have achieved CEOS Analysis Ready Data (CEOS-ARD) compliance, a globally recognized standard established by the Committee on Earth Observation Satellites (CEOS).

CEOS-ARD compliance confirms that EarthDaily data meet rigorous international requirements for radiometric calibration and geometric correction approaches, metadata completeness, and interoperability across time and datasets, enabling immediate quantitative analysis with minimal additional user processing.

Importantly, EarthDaily achieved CEOS-ARD compliance prior to full commercial availability of its complete constellation, a rare milestone for a commercial Earth observation system.

“This achievement validates the scientific foundation of our data,” said Don Osborne, Chief Executive Officer of EarthDaily. “We built the EarthDaily Constellation as a measurement system first. Daily coverage only matters if the data are stable, comparable, and trustworthy over time. CEOS-ARD compliance confirms we are delivering science-grade data at commercial scale.”

CEOS Analysis Ready Data standards are important to science mission interoperability and include a range of public government missions, including Sentinel and Landsat products. The framework was developed to address a persistent challenge in Earth observation: as global data volumes grow, users often lack the infrastructure and expertise required to process raw imagery for scientific and operational applications. Systematic provision of CEOS-ARD reduces that burden and supports more effective decision-making.

EarthDaily’s architecture was intentionally designed to ensure continuity with established scientific archives. Its radiometric calibration approach, spectral configuration, and geometric correction standards enable comparability and compatibility with Landsat and Sentinel data records. This design allows users to integrate EarthDaily data seamlessly into existing time-series analyses while benefiting from enhanced spectral diversity and daily revisit.

Compliance signals that EarthDaily delivers:

  • Science-grade radiometric and geometric correction
  • Interoperable datasets structured for robust time-series analysis
  • Immediate usability for advanced analytics and AI workflows
  • Reduced preprocessing burden and improved analytical reliability

The EarthDaily constellation was engineered around measurement integrity from inception. As highlighted in recent SpaceNews coverage examining the system’s development and on-orbit performance, the EarthDaily Constellation incorporates:

  • Rigorous radiometric calibration
  • Thermal characterization for spectral stability
  • Simultaneous collection across 22 spectral bands
  • Consistent local acquisition timing
  • Architecture aligned for interoperability with Landsat and Sentinel archives

These design principles ensure that EarthDaily data is globally consistent and scientifically reliable for long-term change detection.

With six additional satellites launching in May and continued expansion later this year, the EarthDaily Constellation will enter commercial operations in Summer 2026, delivering daily, consistent global coverage supported by CEOS-ARD compliant science-grade data.

This milestone reinforces EarthDaily’s position as a commercial provider bridging scientific rigor with scalable, AI-ready Earth observation infrastructure.

About EarthDaily

EarthDaily is a global Earth observation company focused on delivering science-grade data and analytics designed for broad-area change detection and decision-centric intelligence. With the upcoming launch of the EarthDaily Constellation, the company is building a foundation for daily, globally consistent Earth intelligence to support governments and enterprises operating in complex, high-impact environments.

To learn more, visit earthdaily.com and follow EarthDaily on LinkedIn (@EarthDaily) and X (@EarthDailyA).

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/a00964c1-54f3-418d-800e-2c09394a2aa3


Contacts
Tanya Cross
Vice President, Global Marketing and Communications
EarthDaily
tanya.cross@earthdaily.com

Alliance Advisors IR
EarthDailyPR@allianceadvisors.com 

SOURCE: EarthDaily Analytics

XSOLLA PROMOTES WOMEN’S LEADERSHIP IN GLOBAL GAMING INDUSTRY

KUALA LUMPUR, March 9 (Bernama) — Xsolla has reaffirmed its commitment to supporting women across the global gaming ecosystem through curated community initiatives, industry events, and thought leadership platforms in key growth markets, including Türkiye, Dubai, and Cyprus.

“By fostering mentorship, creating visible role models, and building meaningful connections between regional talent and global networks, Xsolla helps create real pathways for the next generation of women entering the industry.

“A more inclusive ecosystem drives stronger innovation, better decision-making, and long-term growth for the entire ecosystem,” said Xsolla Vice President of Business Development EMEA, Ilayda Bayari in a statement.

As the gaming industry continues to expand across emerging and high-growth markets, Xsolla is focused on empowering developers globally by fostering an inclusive ecosystem that provides women founders, studio leaders, publishers, and entrepreneurs with greater access to visibility, networks, and opportunities.

Through targeted industry gatherings and community-led discussions, Xsolla has also supported conversations around women in leadership in gaming. Recently, the company hosted an event in Dubai that brought together women founders and senior leaders from across the Middle East and neighbouring markets.

In 2025, Xsolla co-organised the Women in Games Cyprus conference, which gathered more than 70 senior leaders for panels, roundtables and workshops designed to help women and allies connect, collaborate and grow professionally and personally.

With a rapidly growing gaming ecosystem that generated US$1.01 billion in revenue in 2025, Türkiye represents another key focus market. Xsolla sees significant opportunities to support the market by connecting regional talent to the global gaming industry through its international network and sector expertise. (US$1=RM3.95)

Xsolla aims to increase visibility for women leaders and founders in gaming, encourage mentorship and peer-to-peer collaboration, facilitate cross-border connections between regional studios and global markets, and support sustainable growth across emerging gaming hubs.

A global video game commerce company, Xsolla is also championing female leaders within the organisation and across the wider industry through roles in legal, human resources, office leadership, business development, training and customer success.

— BERNAMA

Green Building Initiative Launches Ascent Building Certification™ for Global Markets

New portfolio-ready building certification delivers proven tools to achieve credible sustainability and performance outcomes worldwide

PORTLAND, Ore., March 4 (Bernama-GLOBE NEWSWIRE) — The Green Building Initiative (GBI) announces the global launch of Ascent Building Certification™, a science-based whole building certification designed to evaluate sustainability, health, and resilience practices for all types of commercial real estate across regions and portfolios. Ascent will be used for new and existing projects in the EU, the UK, and elsewhere outside Canada and the United States to improve the built environment’s impact on climate and society.

Ascent Building Certification™ is a global expansion of GBI’s trusted third-party assessment and certification programs. GBI has certified over 93 million square meters (1 billion square feet) of commercial real estate, leading with its flagship certification, Green Globes®. Strong adoption of Green Globes combined with market demand for a robust, proven, and transparent certification that delivers consistent methodology across borders and portfolios led GBI to expand its flagship certification globally under the Ascent™ brand.

Designed for owners and project teams managing assets in all lifecycle phases, Ascent provides a consensus-based framework, consistent with Green Globes, that adapts to local standards and regulatory requirements. The certification responds to growing market demand for certification systems that combine transparency, a trustworthy independent assessment, and practical usability—without unnecessary administrative burden.

“Building owners and investors are facing increasing pressure to demonstrate measurable performance and return on investment across global portfolios,” said Vicki Worden, CEO of GBI. “GBI’s Ascent Building Certification answers that demand with a practical, transparent, and ESG-aligned approach.”

Ascent is designed to serve organizations seeking user-friendly, portfolio-ready certification. Key features include:

  • Global consistency with local relevance through a unified framework adaptable to regional regulations and environmental conditions
  • Transparent scoring and results that support credible reporting and stakeholder confidence
  • Independent third-party assessment conducted through GBI’s established assessor network
  • User-friendly software tools with centralized reporting dashboards and aggregated portfolio scoring
  • Dedicated expert support from GBI’s team of green building specialists and project managers
     

Certification levels align with the Green Globes One through Four rating system, and performance categories address critical building outcomes and Environmental Assessment Areas, including project management and responsible business practices, site, energy, water, materials, and indoor environment.

By combining transparent scoring, independent certification, structured expert guidance, and user-friendly tools, Ascent reduces friction in the certification process while maintaining rigorous performance standards.

Organizations can learn more or begin the certification process at:
https://thegbi.org/assessment-certification/ascent-certification/

For media inquiries, contact megan@thegbi.org.

About GBI

GBI is an international nonprofit organization and American National Standards Institute (ANSI) Accredited Standards Developer dedicated to improving the built environment’s impact on climate and society. Founded in 2004, the organization is the global provider of the Green Globes®, Journey to Net Zero™, Guiding Principles Compliance, and Ascent Building Certification™ and assessment programs. GBI also issues professional credentials, including the Green Globes Professional (GGP) and Guiding Principles Compliance Professional (GPCP). To learn more about opportunities to become involved with GBI, contact info@thegbi.org or visit the GBI website at www.thegbi.org.

MEDIA CONTACT
Megan Baker, GBI Vice President of Engagement, megan@thegbi.org, (971) 256-7174

SOURCE: Green Building Initiative

MEDICAL KOREA 2026 TO SPOTLIGHT FUTURE OF AI-POWERED HEALTHCARE

KUALA LUMPUR, March 3 (Bernama) — Medical Korea 2026, the 16th Global Healthcare & Medical Tourism Conference, will take place from March 19 to 22 at COEX in Seoul under the theme “AI-Powered Global Healthcare: Bringing the Future and the World Closer”.

Hosted by the Ministry of Health and Welfare and organised by the Korea Health Industry Development Institute (KHIDI), the conference will bring together global healthcare leaders, policymakers, and industry experts to discuss the future of artificial intelligence (AI)-powered healthcare and cross-border medical services.

Since its launch in 2010, Medical Korea has provided a platform for global dialogue on healthcare innovation and medical tourism, with this year’s event focusing on how AI is influencing healthcare delivery, digital transformation and international medical collaboration.

“Medical Korea 2026 will bring together global leaders and experts to address the latest trends and key issues in AI-driven healthcare. Through AI-powered innovation, the conference aims to strengthen global collaboration and bring the future of healthcare closer,” said KHIDI Director of the Department of Global Healthcare Business (Inbound), Andy Hong.

According to a statement, the programme includes an Opening Ceremony, eight Conference Sessions, Business Meetings, G2G Meetings, an Exhibition, FAM Tours, and the Medical Korea Gala Dinner.

At the Opening Ceremony, keynote speeches will be delivered by the Ministry of Health and Welfare Director General for Healthcare Industry Policy, Eun-Young Jung and Marx Advisory Chief Executive Officer, Edward Marx.

Meanwhile, the Conference Sessions will feature more than 40 domestic and international speakers discussing AI-driven healthcare innovation, medical tourism strategies, digital health trends and developments in AI-based medical technologies.

Business Meetings will provide structured networking opportunities for overseas patient attraction and international expansion, while G2G Meetings will facilitate discussions on healthcare and medical tourism cooperation between governments and related organisations.

The Exhibition will operate through three pavilions highlighting global healthcare collaboration, the competitiveness of Korea’s medical services industry and the Medical Korea platform, offering an overview of international medical capabilities and partnership opportunities.

— BERNAMA